HUSSMAN STRATEGIC MARKET CYCLE FUND PTGX Holdings History
HUSSMAN STRATEGIC MARKET CYCLE FUND's Protagonist Therapeutics Inc Holding Summary
As of 2025-03-31, HUSSMAN STRATEGIC MARKET CYCLE FUND held 50,000.00 shares of Protagonist Therapeutics Inc(PTGX), totaling $2.42 Mil. This investment constitutes 0.81% of their stock portfolio, and HUSSMAN STRATEGIC MARKET CYCLE FUND now holds 0.08% of the outstanding Protagonist Therapeutics Inc(PTGX) stock.
The initial trade took place in 2024Q4. And since then HUSSMAN STRATEGIC MARKET CYCLE FUND has made 1 purchases of PTGX, at an average price of $43.59, for a total of 100,000.00 shares. In addition, there have been 1 sales at an average price of $41.90 for 50,000.00 shares. Based on historical transaction data and PTGX's current price of $53.00, HUSSMAN STRATEGIC MARKET CYCLE FUND's estimated gain on his PTGX holdings is $386,000.00, reflecting a 8.86% gain to date.
HUSSMAN STRATEGIC MARKET CYCLE FUND PTGX ($53.00) Holding Chart
HUSSMAN STRATEGIC MARKET CYCLE FUND PTGX ($53.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
